Cooley

Megan Browdie

Deals
10
Latest
Jun 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 10 deals
Deals by year
Megan Browdie: deals by year051020252026 YTD: 10 M&A102026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Megan Browdie was named on, most recent first
Jun 2026 First Street –MSCIAcquisitionLegal adviser to First Street (target)Announced120.0Data & Analytics+1MSCI acquisition of First Street
Jun 2026 GPTZero –SuperhumanAcquisitionLegal adviser to GPTZero (target)Announced–AISuperhuman acquisition of GPTZero
May 2026 Vaccine Company –LillyAcquisitionLegal adviser to Vaccine Company (target)Announced1,550.0Biotech+1Lilly acquisition of Vaccine Company
May 2026 Engage Bio –Eli LillyAcquisitionLegal adviser to Engage Bio (target)Announced202.0Biotech+1Eli Lilly acquisition of Engage Bio
May 2026 Peloton Consulting Group –Sunstone PartnersStakeLegal adviser to Peloton Consulting Group (target)Announced–IT Services+1Sunstone Partners stake in Peloton Consulting Group
Apr 2026 Ajax Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Ajax Therapeutics (target)Announced2,300.0Biotech+2Eli Lilly and Company acquisition of Ajax Therapeutics
Mar 2026 PFF enterprise (B2B) business Pro Football FocusTeamworksAsset saleLegal adviser to Pro Football Focus (seller)Announced–Data & AnalyticsTeamworks acquisition of PFF enterprise (B2B) business
Mar 2026 Rivian Automotive –Uber TechnologiesStakeLegal adviser to Uber Technologies (acquirer)Announced300.0Automotive+1Uber Technologies stake in Rivian Automotive
Feb 2026 35Pharma –GSKAcquisitionLegal adviser to 35Pharma (target)Announced950.0Biotech+1GSK acquisition of 35Pharma
Feb 2026 Veros Technologies Razor's EdgeQuantum LeapAcquisitionLegal adviser to Veros Technologies (target)Completed–Cybersecurity+2Quantum Leap acquisition of Veros Technologies

Deals where Megan Browdie is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.